Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinomaSatoru Hagiwara, Toshiharu Sakurai|British Journal of Cancer|2012Cited by 106
A New Prognostic Staging System for Hepatocellular Carcinoma: Value of the Biomarker Combined Japan Integrated Staging ScoreSatoshi Kitai, Takashi Matsunaga, Yasunori Minami et al.|Intervirology|2008Cited by 42
Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesisSatoru Hagiwara, Masatoshi Kudo|Scientific Reports|2017Cited by 5